A Z Monica

The cardiology department at A Z Monica in Antwerp is actively involved in research focused on preventing serious cardiovascular complications. The research primarily addresses atrial fibrillation, a condition characterized by irregular and often rapid heartbeat that significantly increases the risk of stroke and other cardiovascular events.

• Prevention of stroke and systemic embolism in patients with atrial fibrillation
• Evaluation of novel anticoagulation strategies
• Assessment of bleeding risk profiles in cardiovascular interventions
• Comparative effectiveness of therapeutic approaches

Clinical investigations aim to identify safer and more effective treatment options for patients at elevated stroke risk, balancing the prevention of thromboembolic events with the management of bleeding complications.

Research at this Belgian facility extends into the field of oncology, with particular emphasis on neuroendocrine tumours. These rare cancers arise from specialized cells throughout the body and present unique therapeutic challenges requiring specialized treatment approaches.

• Treatment strategies for neuroendocrine tumours following disease progression
• Role of somatostatin analogues in disease management
• Evaluation of second-line therapies including peptide receptor radionuclide therapy
• Quality of life assessment during cancer treatment

The investigations focus on optimizing therapeutic sequences and determining whether continuing certain treatments after initial progression provides clinical benefit, with careful attention to patient-reported outcomes and disease control.